AACR Honors MIT’s Tyler Jacks, PhD, with 2020 Princess Takamatsu Memorial Lectureship for His Remarkable Advancement of Genetically Engineered Mouse Models and for His Seminal Discoveries Related to Oncogenes and Immune System Regulation of Tumor Progress

On May 29, 2020, the American Association for Cancer Research (AACR) announced that it is recognizing Tyler Jacks, PhD, Fellow of the AACR Academy, with the 2020 AACR Princess Takamatsu Memorial Lectureship. Dr. Jacks is Director of the David H. Koch Institute for Integrative Cancer Research at the Massachusetts Institute of Technology (MIT), Co-Director of the Ludwig Center at MIT, and a Howard Hughes Medical Institute (HHMI) Investigator. He is being recognized for transforming cancer research and the development of therapeutic treatments through his remarkable advancement of genetically engineered mouse models and for his seminal discoveries related to oncogenes, tumor suppressor genes, cell death, and immune system regulation of tumor progression. “Dr. Jacks is a highly esteemed cancer scientist, and we are delighted to recognize his exceptional body of innovative work,” said Margaret Foti, PhD, MD (hc), chief executive officer of the AACR. “His ground-breaking research has provided deep insights into cancer initiation and progression, and has led to the identification of promising new treatments for cancer patients worldwide. He is revered for his tremendous research achievements as well as for his commitment to collaborative research across the world.
Login Or Register To Read Full Story